General Information
Version
8.3
Revision date
2024-07-02
Product name
Lovastatin
CAS No.
75330-75-5
1.2.1 Relevant identified uses
Reagent for development and research
Emergency telephone
+64 9 801 0034
Icons in SDS
Company Information
company name
Merck Life Science Ltd
e-mail address of the competent person responsible for the Safety Data Sheet
customersupport.anz@merckgroup.com
GHS Information
Signal word
Warning
Hazard Codes
Hazard statements (CLP)
H302, H351, H361
Hazard statements
Code
Statements
H302
Harmful if swallowed
Section 2
SECTION 2: Hazards identification
2.1 Classification of the substance or mixture
Acute toxicity, Oral (Category 4), H302 Carcinogenicity (Category 2), H351 Reproductive toxicity (Category 2), H361 For the full text of the H-Statements mentioned in this Section, see Section 16.
Signal word
Warning
Hazard statements
H302 Harmful if swallowed. H351 Suspected of causing cancer. H361 Suspected of damaging fertility or the unborn child.
Prevention
P201 Obtain special instructions before use. P202 Do not handle until all safety precautions have been read and understood. P264 Wash skin thoroughly after handling. P280 Wear protective gloves/ protective clothing/ eye protection/ face protection.
Response
P308 + P313 IF exposed or concerned: Get medical advice/ attention.
Disposal
P501 Dispose of contents/ container to an approved waste disposal plant.
Other hazards
- none